We are live on ! Find out more
RE

RBC Europe Portfolio holdings

AUM $2.08B
1-Year Est. Return 12.2%
This Fund
S&P 500
This Quarter Est. Return
+6%
1 Year Est. Return
-12.2%
3 Year Est. Return
+59.81%
5 Year Est. Return
+127.03%
10 Year Est. Return
–
AUM
$1B
AUM Growth
+$95.8M
Cap. Flow
+$49M
Cap. Flow %
4.89%
Top 10 Hldgs %
46.74%
Holding
1,116
New
33
Increased
141
Reduced
150
Closed
45

Top Buys

Rank Stock Value
1
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$12.9M
2
MSFT icon
Microsoft
MSFT
+$8.08M
3
DIS icon
Walt Disney
DIS
+$5.58M
4
V icon
Visa
V
+$4.43M
5
PAYC icon
Paycom
PAYC
+$1.87M

Top Sells

Rank Stock Value
1
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$1.48M
2
USG
Usg
USG
+$1.04M
3
KOS icon
Kosmos Energy
KOS
+$957K
4
GS icon
Goldman Sachs
GS
+$681K
5
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
+$517K

Sector Composition

Rank Sector Weight
1 Financials 24.26%
2 Technology 18.42%
3 Consumer Discretionary 16.46%
4 Communication Services 11.34%
5 Healthcare 9.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SCPX
1051
DELISTED
Scorpius Holdings, Inc.
SCPX
– –
0
– –
GCVRZ
1052
DELISTED
Sanofi Contingent Value Rights
GCVRZ
$68 ﹤0.01%
130
– –
CRIS icon
1053
Curis
CRIS
$3.61M
– –
0
– –
GTE icon
1054
Gran Tierra Energy
GTE
$349M
$48 ﹤0.01%
3
– –
GENE
1055
DELISTED
Genetic Technologies Ltd.
GENE
$47 ﹤0.01%
4
– –
SDRL
1056
DELISTED
Seadrill Limited Common Stock
SDRL
$37 ﹤0.01%
9
– –
NNVC icon
1057
NanoViricides
NNVC
$31.7M
$34 ﹤0.01%
7
– –
GRCE
1058
Grace Therapeutics
GRCE
$44.6M
$34 ﹤0.01%
1
– –
FCSC
1059
DELISTED
Fibrocell Science Inc.
FCSC
$27 ﹤0.01%
14
– –
LSTA icon
1060
Lisata Therapeutics
LSTA
$15.2M
$23 ﹤0.01%
1
– –
FTR
1061
DELISTED
Frontier Communications Corp.
FTR
$21 ﹤0.01%
12
– –
SNOA icon
1062
Sonoma Pharmaceuticals
SNOA
$6.27M
– –
0
– –
OPTT icon
1063
Ocean Power Technologies
OPTT
$46.2M
$13 ﹤0.01%
7
– –
ADXS
1064
DELISTED
Advaxis Inc
ADXS
$8 ﹤0.01%
+4
New +$13
OIBR.C
1065
DELISTED
OI S.A. American Depositary Shares, each representing five shares of common stock
OIBR.C
$8 ﹤0.01%
4
– –
VIVE
1066
DELISTED
VIVEVE MED INC
VIVE
– –
0
– –
MBOT icon
1067
Microbot Medical
MBOT
$99.4M
$5 ﹤0.01%
1
– –
PALI icon
1068
Palisade Bio
PALI
$349M
– –
0
– –
DRIO icon
1069
DarioHealth
DRIO
$66.3M
– –
0
– –
APEN
1070
DELISTED
Apollo Endosurgery, Inc.
APEN
$3 ﹤0.01%
1
– –
AVY icon
1071
Avery Dennison
AVY
$13.5B
– –
-380
Closed -$42.9K
BRKR icon
1072
Bruker
BRKR
$8.7B
– –
-265
Closed -$10.2K
CRBP icon
1073
Corbus Pharmaceuticals
CRBP
$211M
– –
-107
Closed -$22.2K
DAVA icon
1074
Endava
DAVA
$170M
– –
-18,000
Closed -$495K
DHI icon
1075
D.R. Horton
DHI
$41.2B
– –
-775
Closed -$32.1K
41 42
43
44 45

Similar funds

AP
Advisor Partners Walnut Creek, California $1.42B AUM 3.97% 1-Year Est. Return
AWM
Altium Wealth Management Purchase, New York $1.39B AUM 12.44% 1-Year Est. Return
FWM
Frontier Wealth Management Kansas City, Missouri $1.38B AUM 6.3% 1-Year Est. Return
BRWM
B. Riley Wealth Management Memphis, Tennessee $962M AUM 8.45% 1-Year Est. Return
BDWM
Brewin Dolphin Wealth Management Conskleagh, Dublin, Ireland $917M AUM 12.3% 1-Year Est. Return
DHFB
Dixon Hubard Feinour & Brown Roanoke, Virginia $842M AUM 2.74% 1-Year Est. Return
MCM
Murphy Capital Management Bedminster, New Jersey $720M AUM 9.22% 1-Year Est. Return
TFM
TPI Fund Managers London, United Kingdom $597M AUM 7.13% 1-Year Est. Return

RBC Europe's Q2 2019 Portfolio in Review

As of Q2 2019, RBC Europe held 1,116 positions worth $1B, up 11% from $905M the previous quarter. Its ten largest holdings account for 47% of the portfolio.

RBC Europe deployed $49M of net new capital in Q2 2019, opening 33 new positions and adding to 141 existing holdings. Its largest new stake was Paycom: 9,110 shares worth $2.07M.

By sector, the portfolio is most concentrated in Financials at 24% of assets, up from 23% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Alphabet (Google) Class A, an estimated $1.48M trimmed.

  • RBC Europe's largest Q2 2019 buy was Paycom: 9,110 shares worth $2.07M.
  • RBC Europe added most to Berkshire Hathaway Class B in Q2 2019, an estimated $12.9M increase.
  • RBC Europe's biggest Q2 2019 reduction was Alphabet (Google) Class A, cutting an estimated $1.48M.
  • RBC Europe fully exited Usg in Q2 2019, selling an estimated $1.04M.
  • RBC Europe's ten largest holdings make up 47% of its $1B portfolio in Q2 2019.
  • RBC Europe opened 33 new positions and closed 45 in Q2 2019.
  • RBC Europe's portfolio value rose 11% quarter-over-quarter to $1B.

Based on RBC Europe's 13F filing for Q2 2019, filed 9 Nov 2023.